Jan Aldershvile

5.1k total citations
115 papers, 2.9k citations indexed

About

Jan Aldershvile is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Hepatology. According to data from OpenAlex, Jan Aldershvile has authored 115 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 42 papers in Cardiology and Cardiovascular Medicine and 35 papers in Hepatology. Recurrent topics in Jan Aldershvile's work include Hepatitis B Virus Studies (36 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Jan Aldershvile is often cited by papers focused on Hepatitis B Virus Studies (36 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Jan Aldershvile collaborates with scholars based in Denmark, Germany and United States. Jan Aldershvile's co-authors include Søren Boesgaard, Peter Kryger, Jens Nielsen, Gitte M. Knudsen, Fin Stolze Larsen, Kim Krogsgaard, Nicolai Gruhn, Jens Erik Nielsen‐Kudsk, S. Boesgaard and Henrik E. Poulsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Gastroenterology.

In The Last Decade

Jan Aldershvile

110 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Aldershvile Denmark 32 1.1k 966 722 510 416 115 2.9k
Giuseppe Bárbaro Italy 38 2.0k 1.9× 1.1k 1.2× 476 0.7× 320 0.6× 1.1k 2.7× 124 4.7k
F Balsano Italy 30 766 0.7× 839 0.9× 627 0.9× 329 0.6× 691 1.7× 116 3.3k
Daniel Yeshurun Israel 30 494 0.5× 705 0.7× 501 0.7× 295 0.6× 805 1.9× 136 3.1k
L Chiandussi Italy 25 773 0.7× 761 0.8× 910 1.3× 279 0.5× 727 1.7× 96 2.8k
Else Marit Løberg Norway 27 218 0.2× 1.1k 1.1× 260 0.4× 256 0.5× 380 0.9× 71 3.2k
W. J. Kox Germany 26 323 0.3× 546 0.6× 179 0.2× 163 0.3× 680 1.6× 71 2.3k
George M. Matuschak United States 28 214 0.2× 1.0k 1.1× 222 0.3× 431 0.8× 631 1.5× 84 3.5k
Bruno Schneeweiß Austria 33 140 0.1× 938 1.0× 647 0.9× 458 0.9× 780 1.9× 91 3.3k
Rajarshi Banerjee United Kingdom 32 1.1k 1.0× 2.2k 2.2× 1.1k 1.6× 502 1.0× 515 1.2× 99 4.1k
Jacques J. Bourgoignie United States 34 470 0.4× 349 0.4× 198 0.3× 224 0.4× 438 1.1× 101 3.4k

Countries citing papers authored by Jan Aldershvile

Since Specialization
Citations

This map shows the geographic impact of Jan Aldershvile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Aldershvile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Aldershvile more than expected).

Fields of papers citing papers by Jan Aldershvile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Aldershvile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Aldershvile. The network helps show where Jan Aldershvile may publish in the future.

Co-authorship network of co-authors of Jan Aldershvile

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Aldershvile. A scholar is included among the top collaborators of Jan Aldershvile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Aldershvile. Jan Aldershvile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Toivonen, L., et al.. (2003). 688 The effect of levosimendan on all-cause mortality and mode of death in patients with severe heart failure. European Journal of Heart Failure Supplements. 2(1). 141–141. 1 indexed citations
3.
Hove, Jens Dahlgaard, Klaus F. Kofoed, Søren Holm, et al.. (2003). Simultaneous cardiac output and regional myocardial perfusion determination with PET and nitrogen 13 ammonia. Journal of Nuclear Cardiology. 10(1). 28–33. 6 indexed citations
4.
Lindholm, Matias Greve, et al.. (2003). Effect of Early Revascularisation in Cardiogenic Shock Complicating Acute Myocardial Infarction. A Single Center Experience. European Journal of Heart Failure. 5(1). 73–79. 6 indexed citations
5.
Vejlstrup, Niels, Claus B. Andersen, Søren Boesgaard, Svend Aage Mortensen, & Jan Aldershvile. (2002). Temporal changes in myocardial endothelial nitric oxide synthase expression following human heart transplantation. The Journal of Heart and Lung Transplantation. 21(2). 211–216. 12 indexed citations
6.
Boesgaard, Søren, Nicolai Gruhn, Michael Wanscher, et al.. (2001). Treatment Strategies in Cardiogenic Shock Complicating Acute Myocardial Infarction. 1(3). 176–181.
7.
Aldershvile, Jan, et al.. (2000). [Circulatory support with the mechanical heart, "HeartMate"].. PubMed. 162(26). 3717–22. 1 indexed citations
8.
Nielsen‐Kudsk, Jens Erik, Nicolai Gruhn, Simon Trautner, et al.. (1998). Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels. European Journal of Pharmacology. 361(1). 43–49. 36 indexed citations
9.
Vejlstrup, Niels, Anne Bouloumié, Søren Boesgaard, et al.. (1998). Inducible Nitric Oxide Synthase (iNOS) in the Human Heart: Expression and Localization in Congestive Heart Failure. Journal of Molecular and Cellular Cardiology. 30(6). 1215–1223. 88 indexed citations
10.
Høst, Nis, Jan Aldershvile, Kim Hørslev‐Petersen, S. Høyer, & Stig Haunsø. (1996). Serum aminoterminal propeptide of type III procollagen after cardiac transplantation and the effect of rejection. The American Journal of Cardiology. 78(12). 1406–1410. 6 indexed citations
11.
Boesgaard, S., et al.. (1996). Nitrate tolerance impairs nitric oxide-mediated vasodilation in vivo. Cardiovascular Research. 31(5). 814–819. 37 indexed citations
12.
Hesse, Birger, et al.. (1995). Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.. PubMed. 14(1 Pt 1). 23–31. 14 indexed citations
13.
Boesgaard, Søren, Henrik Wroblewski, Henrik E. Poulsen, et al.. (1994). Altered peripheral vesodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine. Journal of the American College of Cardiology. 23(1). 163–169. 24 indexed citations
14.
Kelbæk, Henning, et al.. (1992). Evaluation of left-to-right shunts in adults with atrial septal defect using first-pass radionudide cardiography. European Heart Journal. 13(4). 491–495. 2 indexed citations
15.
Aldershvile, Jan, et al.. (1988). Combined first pass and equilibrium radionuclide cardiographic determination of stroke volume for quantitation of valvular regurgitation. Journal of the American College of Cardiology. 11(4). 769–773. 10 indexed citations
16.
Krogsgaard, Kim, Peter M. H. Heegaard, Jan Aldershvile, et al.. (1988). Delta Infection and Hepatitis B Virus Replication in Danish Patients with Fulminant Hepatitis B. Scandinavian Journal of Infectious Diseases. 20(2). 127–133. 6 indexed citations
17.
Gluud, Christian, et al.. (1984). Prevalence of hepatitis B virus infection in out-patient alcoholics. Infection. 12(2). 72–74. 10 indexed citations
18.
Caporaso, N., et al.. (1983). The significance of the HBe system in an area highly endemic for hepatitis B virus. Infection. 11(1). 13–16. 2 indexed citations
19.
Orholm, Marianne, Jan Aldershvile, Ulrik Tage‐Jensen, et al.. (1981). Prevalence of hepatitis B virus infection among alcoholic patients with liver disease.. Journal of Clinical Pathology. 34(12). 1378–1380. 43 indexed citations
20.
Wantzin, P., Jan Aldershvile, H Jans, E. Dybkjær, & Jens Nielsen. (1981). The Prognosis of the Healthy HBsAg Carrier State. Scandinavian Journal of Gastroenterology. 16(8). 1077–1081. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Bárbaro Breakdown of academic impact, for papers by F Balsano Breakdown of academic impact, for papers by Daniel Yeshurun Breakdown of academic impact, for papers by L Chiandussi Breakdown of academic impact, for papers by Else Marit Løberg Breakdown of academic impact, for papers by W. J. Kox Breakdown of academic impact, for papers by George M. Matuschak Breakdown of academic impact, for papers by Bruno Schneeweiß Breakdown of academic impact, for papers by Rajarshi Banerjee Breakdown of academic impact, for papers by Jacques J. Bourgoignie
Rankless by CCL
2026